Now, as easy as putting on glasses, Alzheimer’s sufferers can improve cognitive function by up to 50% with MemorySPEX™ in the comfort of their own homes, or in any setting, for as little as twenty minutes a day, while allowing them to watch TV, spend time with loved ones, or partake in other normal activity.
Heugenis is a Medical Wearable Technology company whose mission is to bring hope and increase the quality of life to 46 million Alzheimer’s sufferers globally through a low-cost, non-drug appliance, while putting unprecedented control in the hands of patients and doctors.
Leveraging cutting-edge research proven in clinical trials to improve cognitive functions in the brain related to the disease by up to 50%, we are launching our patent-pending flagship product MemorySPEX™ direct to consumers across the global marketplace in 2019.
There are currently no effective treatments for Alzheimer’s disease. Drugs are clearly not the answer; they’re expensive and they don’t work. Groundbreaking research is advancing treatment options in a historic way. Our new product MemorySPEX makes this groundbreaking research available for the first time to millions globally who are desperate for relief from fear, emotional suffering, and the intense financial strain of Alzheimer’s disease.
Decades of research by prominent universities has successfully shown that stroboscopic therapy increases cognitive functions, and new research out of MIT has shown that it can reduce the effects of Alzheimer’s disease by up to 50 percent. NASA developed stroboscopic therapy to treat space sickness in astronauts returning from the MIR space station and world-class professional athletes have been recently using it to sharpen their brains and their game. Now MemorySPEX brings this new technology to 46 million Alzheimer’s sufferers globally, providing the consumer with the choice to try our safe, non-drug and non-invasive therapy under the supervision of their doctor’s care and in concert with existing drug regimens, without a prescription.
Each pair of MemorySPEX will connect via Bluetooth to our custom-designed smartphone app to record the user’s time and length of treatment, then upload this information to our web-based Doctor-Patient Portal, or MemorySPEX Portal™, allowing personal physicians the ability to monitor, measure and custom-tailor their treatment protocol in partnership with our platform’s AI ‘decision support system,’ providing patients, loved ones, and caregivers proof that they are getting the care they need, while delivering measurable results that can change the lives of millions.
Proof it Works
MemorySPEX can not only record patient’s data to our MemorySPEX Portal for doctor review, it can provide proof it is working through an accessory to our glasses that can measure and report neurological activity in areas in the brain related to Alzheimer’s disease, allowing doctors to remotely treat their patients without the need of time-consuming appointment visits and the stress of getting your loved one there.
How Does It Work in LAYMAN’S TERMS?
Certain electrical oscillations (waves) in the neurons’ network interaction of the brain are shown to be out of sync in Alzheimer’s sufferers. The frequency range of the stroboscopic effect from our MemorySPEX, along with auditory stimulation (at optimal range of 40Hz) produces gamma oscillations (invisible waves from the lenses through the brain) which are shown to reduce the toxic protein accumulation or plaque on the brain by up to 50%, increasing cognitive function and halting the progression of the disease and reversing its symptoms.
Unlike conventional strobe lights, which emit bursts of flashing lights (an invasive stimuli), MemorySPEX do not emit any type of light whatsoever. In fact, it produces a strobe-like effect by momentarily blocking out natural ambient light (a noninvasive stimuli) in much the same way as blinking does. By using LCD (Liquid Crystal Display) lens technology, MemorySPEX have a functionality of blocking ambient light by electronically switching the lenses from clear to opaque, much like shaded sunglasses. There is no obtrusive light that enters the eyes except natural daylight.
Hope For Millions
There are now 46 million people with Alzheimers disease worldwide and that number is expected to explode to 160 million by 2050. There are 5.8 million Americans living with Alzheimer’s Disease in 2019, and 1 in 3 adults in the U.S. will die from Alzheimer’s or age-related dementia as our population ages, affecting almost everyone as a patient or a caregiver. There is a desperate plea for an alternative treatment from patients, physicians, caregivers and family members that is rising to a critical pitch.
Alzheimer’s disease has become a global epidemic with no end in sight. Besides the heart-breaking personal suffering of patients and their caregivers, its exploding costs will put budget-busting demands on Medicare as the number of sufferers explodes in the next 30 years. The total healthcare costs to society associated with A.D. will reach 2 trillion dollars by 2030, greater than cancer and heart disease.
Two major pharmaceutical companies saw their new drugs fail in stage three clinical testing in the last year; there is nothing new in the drug pipeline for at least seven years. In addition, three pharmaceutical companies abandoned their Alzheimer’s drug development programs in 2019 because the benefits of current pharmaceutical treatments no longer outweigh the risks[1].
[1] https://www.novartis.com/news/media-releases/novartis-amgen-and-banner-alzheimers-institute-discontinue-clinical-program-bace-inhibitor-cnp520-alzheimers-prevention
The Research behind MemorySPEX
Research out of MIT, published in the medical journal Nature and reported by the National Institute of Health, demonstrates that Alzheimer’s disease disrupts the way neurons in the brain synchronize, or the ‘gamma rhythm.’[1]Reduced gamma rhythms are due in part to the toxic accumulation of a protein in the brain called Amyloid Beta, or plaque. In clinical studies on mice suffering from Alzheimer’s disease, the gamma rhythm was more significantly decreased in a brain region crucial for learning and memory—the hippocampus; the diminished gamma rhythm occurred with the accumulation of amyloid beta, or plaque, which eventually becomes toxic and results in death of neurons in the brain, resulting in memory loss.
The same clinical study showed that stimulating neurons in the AD mice by flashing light at a 40 Hertz range cut plaque levels nearly in half while simultaneously activating genes in brain cells called microglia. Microglia are part of the brain’s immune system that eat away amyloid beta. The same remarkable success shown in mice was demonstrated in human patients suffering from Alzheimer’s disease in a follow-up study by researchers from MIT.
[1] https://www.nia.nih.gov/news/noninvasive-brain-wave-treatment-reduces-alzheimers-pathology-improves-memory-mice
However, for the plaque levels to remain low, the flashing light treatment had to be given over several days versus hours, and once it was stopped, patients saw an almost immediate return to memory loss. Our new wearable appliance MemorySPEX utilizes stroboscopic technology to deliver 40 Hertz stimulation in the comfort of your own home for as little as twenty minutes a day, using noninvasive ambient light to create the same effects of the study’s flashing light without the triple seizure risk in susceptible patients, without a prescription, and without dangerous drug interactions, offering patients the possibility to halt and even reverse the symptoms of a heartbreaking disease that currently has no effective treatments.
Our Founders have a demonstrated track record for bringing innovative ideas to the global marketplace. Our combined experience spans decades and includes launching, management and growth of national and international businesses, leveraging design, marketing, sales, fiscal management, engineering and operational expertise.
Visit www.memoryspex.com to learn more or call Founder Kim Lavine at 616-502-7296 or email at kim@memoryspex.com today.
![Heugenis.com is excited to announce that we are a part of the @ [Nashville Entrepreneur Center]’s 2020 Project Healthcar...](https://img5.findhealthclinics.com/994/305/314222029943058.jpg)
